Staff Profile

Edit

Career Summary

Biography

Professor Martin is a dual trained clinical pharmacologist and practising general physician. She has studied politics and health economics at Oxford University as a Rhodes Scholar and has used this experience to serve on the Pharmaceutical Benefits Advisory Committee, the Economic Subcommittee of the PBAC and other Government and Statewide committees examining appropriate allocation, regulation, safety and efficacy in pharmaceuticals. She is a Member of the Australian Institute of Company Directors (Diploma).

Her PhD (Monash) examined innate immunity in Type 2 diabetes and subsequent postdoctoral work at the Walter and Eliza Hall focussed on the function of macrophages with high fat diet. Her recent research is in the area of clinical development of both novel and old drugs for a variety of diseases and has developed a collaboration with Leiden University using clinical pharmacological methods generally to improve dosing, with EKUT (Germany) in the combined role of therapeutic drug monitoring (TDM) and pharmacogenetics to individualise choice and dose of chemotherapy, and with the National Institutes of Health in identifying and managing synthetic drugs of abuse.

Her current PhD students are researching cannabinoid therapies, targeted cancer therapies, dosing in neonates and therapeutic drug monitoring in clinical care including with antimicrobial therapies. Professor Martin is passionate about teaching in the area of clinical pharmacology and been involved in curriculum development for medical students (Otago, Monash, Queensland and Melbourne Universities) was the recent teaching and learning representative on the STC in clinical pharmacology for the College of Physicians (RACP). She is currently a member of the RACP Policy and Advocacy Committee, the Council of the Australasian Society for Clinical and Experimental Pharmacology and Therapeutics, and a member of the Pharmacology and Therapeutics Advisory Committee of PHARMAC, the sole purchaser for pharmaceuticals in New Zealand.

Qualifications

  • PhD, Monash University, 21/03/2006
  • Master of Arts, University of Oxford - UK, 26/10/2011
  • Bachelor of Medicine & Surgery, University of Otago - New Zealand, 11/12/1993

Research

Research keywords

  • Clinical pharmacology
  • Personalized medicine
  • Pharmaceutical pricing and regulation
  • Targeted therapies

Research expertise

Professor Jennifer Martin is Chair of Clinical Pharmacology in the School of Medicine and Public Health at the University of Newcastle and a practicing general physician at the Calvary Mater Hospital Newcastle

Fields of Research

CodeDescriptionPercentage
111502Clinical Pharmacology And Therapeutics50
111204Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)30
110399Clinical Sciences Not Elsewhere Classified20

Memberships

Body relevant to professional practice.

  • Member - Australian Society of Clinical and Experimental Pharmacologists and Toxicologists
  • Member - Pharmacogenetics; Education ASCEPT (SIG)
  • Member - Clinical Advisory Group “Closing the Divide in Indigenous Cancer” Queensland Institute Medical Research
  • Member - PAH Clinical Council
  • Member - Diamantina Health Partners Neuroscience and Recovery Centre Steering Committee
  • Member - National Prescribing Service Executive – RADAR
  • Member - QH Medicines Advisory Committee
  • Member - IATDMCT Standard Laboratory Practices (SLP) committee
  • Member - IATDMCT Oncology Committee
  • Member - Editorial Advisory Group National Prescribing Service
  • Member - UQ Discipline of Medicine Research Symposium Organising Committee and Sessional Chair
  • Member - University of South Australia Sansom Institute Research Advisory Board
  • Member - Medical Journal of Australia (MJA) Insight; Australian Doctor
  • Member - Medical Observer

Committee/Associations (relevant to research).

  • Member - Queensland Health Medicines Advisory Committee
  • Member - Queensland Health Improving Presribing Steering Committee
  • Member - Association of Scientific and Clinical Pharmacologists and Toxicologists
  • Member - Diamantina Health Partners Evidence and Innovation Theme
  • Member - Diamantina Health Partners Symposium Organising Committee
  • Member - Therapeutic Guidelines Working Group

Editorial Board.

  • Member - Australian Medicine Handbook
  • Editor - Therapeutic Advances in Drug Safety
  • Editor - British Journal of Clinical Pharmacology
  • Editor - Internal Medicine Journal
  • Editor - Australian Prescriber
  • Editor - Journal Clinical Toxicology

Awards

Finalist

2014Finalist Royal Australasian College of Physicians Teaching Award
Royal Australasian College of Physicians Teaching Award (Australia)
Finalist Royal Australasian College of Physicians Teaching Award
2010Finalist Clinical Educator of the Year
Postgraduate Medical Council Queensland (Australia)
Finalist Clinical Educator of the Year

Nominee

2010Nominee Teaching Award for Junior Medical Staff
PAH Research Week (Australia)
Nominee Teaching Award for Junior Medical Staff

Recognition.

1999"Best Registrar" teaching award for 5th year medical students
Christchurch School of Medicine, Otago University (New Zealand)
"Best Registrar" teaching award for 5th (1999 co-award) year medical students
1998"Best Registrar" teaching award for 4th year medical students
Christchurch School of Medicine, Otago University (New Zealand)
"Best Registrar" teaching award for 4th year medical students

Research Award.

2014University of Queensland Teaching Award
RBWH Clinical School, Faculty of Health Sciences, University of Queensland (Australia)
University of Queensland Teaching Award
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Chapter (14 outputs)

YearCitationAltmetricsLink
2012Martin JH, Somogyi A, 'Pharmacogenomics and Warfarin Therapy', Therapeutic Drug Monitoring, Academic Press, London 161-174 (2012)
2007Martin JH, Krum H, 'Statin therapy in the prevention and treatment of heart failure', The Year In Heart Failure, Clinical Publishing, Atlas Medical Publishing, UK . (2007)
2007Martin JH, Krum H, Gilbert R, 'Interactions between antihypertensive drugs and other medications', Comprehensive hypertension, Elsevier, New York (2007)
2007Martin JH, 'Getting to know your drugs', Therapeutic Guidelines, Therapeutic Guidelines 2007 Endocrinology Group, . 161-174 (2007)
2007Martin JH, 'Contraception', Therapeutic Guidelines 2007, Therapeutic Guidelines 2007, . . (2007)
2006Martin JH, 'Cardiovascular Drugs', Australian Medicines Handbook (7th Ed), Australian Medicines Handbook, Melbourne . (2006)
2003Martin JH, Liew D, Johnson S, 'Benzodiazepines', Alcohol and Drug Problems - A Case Studies Workbook, Oxford University Press, South Melbourne 132-157 (2003)
2003Martin JH, Johnson S, Liew D, 'Cannabis, Hallucucinogens and CNS Stimulants', Alcohol and Drug Problems - A Case Studies Workbook, Oxford University Press, South Melbourne 61-97 (2003)
2003Martin JH, Sim M, Hulse G, 'Opioids', Alcohol and Drug Problems- A Case Studies Workbook, Oxford University Press, South Melbourne 1-34 (2003)
2002Martin JH, Todd F, McLean S, Krum H, Copeland J, 'Cannabis', Management of alcohol and drug problems, Oxford University Press, Adelaide 141-157 (2002)
2002Martin JH, Cape G, Hulse G, Robinson G, McLean S, Saunders J, Young R, 'Sedative-Hypnotics', Management of alcohol and drug problems, Oxford University Press, Adelaide 212-227 (2002)
2002Martin JH, White J, Krum H, McLean S, Young R, Saunders J, 'Hallucinogens', Management of alcohol and drug problems, Oxford University Press, Adelaide 229-238 (2002)
2002Martin JH, Krum H, Haas S, Gilbert R, 'Metabolic co-morbid conditions in heart failure: Diabetes and hypercholesterolemia', Heart Failure Annual, Heart Failure Annual, London 35-58 (2002)
2002Martin JH, Young R, Saunders J, Hulse G, McLean S, Robinson G, 'Opiods', Management of alcohol and drug problems, Oxford University Press, Adelaide 79-99 (2002)
Show 11 more

Journal article (118 outputs)

YearCitationAltmetricsLink
2015Lim AE, Tate JR, Clarke D, Norris RL, Morris RG, Martin JH, 'Clinical Consequences of a Miscalibrated Digoxin Immunoassay', THERAPEUTIC DRUG MONITORING, 37 104-109 (2015)
2015Liu X, Vitetta L, Kostner K, Crompton D, Williams G, Brown WJ, et al., 'The effects of tai chi in centrally obese adults with depression symptoms', Evidence-based Complementary and Alternative Medicine, 2015 (2015)
2015Hosein AN, Lim YC, Day B, Stringer B, Rose S, Head R, et al., 'The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.', J Neurooncol, 122 263-271 (2015)
2015Diaz A, Moore SP, Martin JH, Green AC, Garvey G, Valery PC, 'Factors associated with cancer-specific and overall survival among Indigenous and non-Indigenous gynecologic cancer patients in Queensland, Australia: a matched cohort study.', Int J Gynecol Cancer, 25 542-547 (2015)
2015Hubbard RE, Peel NM, Scott IA, Martin JH, Smith A, Pillans PI, et al., 'Polypharmacy among inpatients aged 70 years or older in Australia.', Med J Aust, 202 373-377 (2015)
2015Martin JH, Ferro A, 'From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the box.', Br J Clin Pharmacol, 79 165-167 (2015)
2015Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al., 'Reducing inappropriate polypharmacy: the process of deprescribing.', JAMA Intern Med, 175 827-834 (2015)
2015Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, Barras M, 'The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'', SUPPORTIVE CARE IN CANCER, 23 71-78 (2015)
2014Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, et al., 'Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease', Clinical Gastroenterology and Hepatology, 12 2092-2103 (2014) [C1]
2014Jellis CL, Sacre JW, Wright J, Jenkins C, Haluska B, Jeffriess L, et al., 'Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy.', European heart journal cardiovascular Imaging, 15 776-786 (2014) [C1]
2014Fay MF, Martin JH, Rose S, 'New imaging techniques for more effective treatment in glioblastoma', Internal Medicine Journal, 44 5-6 (2014) [C3]
2014Williams MM, Taylor PJ, Page CB, Martin JH, 'Clinical research in synthetic cannabinoids - do we need a national approach?', Med J Aust, 201 317-319 (2014) [C3]
2014Theile DE, Scott IA, Martin JH, Gavrilidis A, 'Enabling the success of academic health science centres in Australia: where is the leadership?', The Medical journal of Australia, 201 636-638 (2014) [C3]
2014Martin JH, Coombes I, 'Mortality from common drug interactions systems, knowledge and clinical reasoning to optimise prescribing', Internal Medicine Journal, 44 621-624 (2014) [C3]
2014Fagan KJ, Irvine KM, McWhinney BC, Fletcher LM, Horsfall LU, Johnson L, et al., 'Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers', BMC GASTROENTEROLOGY, 14 (2014)
2014Moore SP, Green AC, Bray F, Garvey G, Coory M, Martin J, Valery PC, 'Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients', BMC CANCER, 14 (2014)
2014Sullivan CM, Staib A, Flores J, Aggarwal L, Scanlon A, Martin JH, Scott IA, 'Aiming to be NEAT: Safely improving and sustaining access to emergency care in a tertiary referral hospital', Australian Health Review, 38 564-574 (2014)
2014Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, et al., 'Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease', CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12 2092-U383 (2014)
2014Carroll JP, Protani MM, Linda N, Cheng ME, Fay M, Saleem M, et al., 'Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women', MEDICAL ONCOLOGY, 31 (2014)
2014Arpon DR, Gandhi MK, Martin JH, 'A new frontier in haematology - Combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug', British Journal of Clinical Pharmacology, 78 274-281 (2014)
2014Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Barras M, 'Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches', SUPPORTIVE CARE IN CANCER, 22 1113-1119 (2014)
2014Morais C, Small D, Vesey D, Martin JH, Johnson D, Gobe G, 'Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy', Biochemical and Biophysical Research Communications, 444 332-337 (2014)
2014Leung J, McKenzie S, Martin JH, Dobson A, McLaughlin D, 'Longitudinal patterns of breast cancer screening: Mammography, clinical, and breast self-examinations in a rural and urban setting', Women's Health Issues, 24 e139-e146 (2014)
2013Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA, 'Deciding when to stop: Towards evidence-based deprescribing of drugs in older populations', Evidence-Based Medicine, 18 121-124 (2013) [C3]
2013Chachay VS, Martin JH, Prins JB, Whitehead JP, O'Moore-Sullivan TM, Lee P, et al., 'Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: A randomised, double blind, placebo-controlled trial', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28 78-79 (2013) [E3]
2013Phillips LK, Peake JM, Zhang X, Hickman IJ, Briskey DR, Huang BE, et al., 'Postprandial total and HMW adiponectin following a high-fat meal in lean, obese and diabetic men', European Journal of Clinical Nutrition, 67 377-384 (2013)
2013Dimeski G, Silvester B, Ungerer J, Johnson L, Martin JH, 'Policy change to improve pathology turnaround time and reduce costs - Possible to do both?', Biochemia Medica, 23 296-302 (2013)
2013Fagan KJ, Irvine KM, McWhinney BC, Fletcher LM, Horsfall LU, Johnson LA, et al., 'BMI But Not Stage or Etiology of Nonalcoholic Liver Disease Affects the Diagnostic Utility of Carbohydrate-Deficient Transferrin', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 37 1771-1778 (2013)
2013Martin JH, Chachay V, Prins J, Whitehead J, O'Moore-Sullivan T, Lee P, et al., 'Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: a randomised, double blind, placebo-controlled trial', Journal of Gastroenterology and Hepatology, 28 78-79 (2013)
2013Martin JH, Hubbard RE, Peel NM, Scott IA, Pillans PI, Gray LC, 'Polypharmacy among Older Inpatients in Australia', Australasian Journal on Ageing, 32 24 (2013)
2013Martin JH, Fagan K, Irvine K, McWhinney B, Fletcher L, Horsfall L, et al., 'BMI but not aetiology or stage of liver disease affects the diagnostic sensitivity of carbohydrate deficient transferrin', Alcoholism: Clinical and Experimental Research, 37 1771-1778 (2013)
2013Martin JH, Forbes M, Raj A, Lampe G, Powell E, '"Khat-associated hepatitis"', Medical Journal of Australia, 199 498-499 (2013)
2013Martin JH, 'Smoking and drug interactions', Australian Prescriber, 36 102-104 (2013)
2012Martin JH, Saleem M, Looke D, 'Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology', British Journal of Clinical Pharmacology, 73 685-690 (2012)
2012Scott IA, Gray LC, Martin JH, Mitchell CA, 'Minimizing inappropriate medications in older populations: A 10-step conceptual framework', American Journal of Medicine, 125 (2012)
2012Martin JH, Theile DE, Ho KKY, Frazer IH, 'Diamantina health partners: Integrating leadership in research, research translation, education and clinical care', Medical Journal of Australia, 196 237-239 (2012)
2012Saleem M, Dimeski G, Kirkpatrick CM, Taylor PJ, Martin JH, 'Target Concentration Intervention in Oncology: Where Are We At?', THERAPEUTIC DRUG MONITORING, 34 257-265 (2012)
2012Carroll J, Protani M, Walpole E, Martin JH, 'Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: A systematic review', Breast Cancer Research and Treatment, 136 323-330 (2012)
2012Scott IA, Gray LC, Martin JH, Mitchell CA, 'Effects of a drug minimization guide on prescribing intentions in elderly persons with polypharmacy.', Drugs & aging, 29 659-667 (2012)
2012Martin JH, Yamashiro Y, Gazarian M, Kling S, Nakamura H, Matsui A, et al., 'Drug Development: The Use of Unlicensed/Off-label Medicines in Pedatrics', J Clin Gastroenterol Nurt, 55 506-510 (2012)
2012Martin JH, Norris R, Barra M, 'Gentamicin Use ¿ More Clinical Outcome Evidence Needed', J Clinic Toxicol, 2 e110 (2012)
2012Roberts JA, Norris R, Paterson DL, Martin JH, 'Therapeutic drug monitoring of antimicrobials', BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 73 27-36 (2012)
2012Duley JA, Somogyi AA, Martin JH, 'The future of thiopurine pharmacogenomics', Pharmacogenomics, 13 1549-1552 (2012)
2012Scott IA, Gray LC, Martin JH, Mitchell CA, 'Effects of a drug minimization guide on prescribing intentions in elderly persons with polypharmacy', Drugs and Aging, 29 659-667 (2012)
2012Martin JH, Moore S, Green A, Garvey G, Corry M, Valery P, 'Breast Cancer diagnosis and patterns of treatment: does being indigenous make a difference?', Asia-Pacific Journal of Clinical Oncology, 8 304 (2012)
2012Martin JH, Jellis C, Sacre J, Wright J, Jenkins C, Jeffriess L, et al., 'A Randomised Trial of Spironolactone use in Subclinical Diabetic Cardiomyopathy: Anti-Fibrotic Effects on Myocardial Structure and Function', Heart Lung and Circulation, 21 . (2012)
2012Martin JH, Valery PC, Moore SP, Coory M, Martin J, Garvey G, Green AC, 'Advanced stage at diagnosis and worse comorbidity explain overall survival disparities between Indigenous and non-Indigenous cancer patients in Queensland', Asia Pac J Clin Oncol, 8 212* (2012)
2012Martin JH, Moore SP, Diaz A, Green AC, Garvey G, Coory M, Valery PC, 'Indigenous women with gynaecological cancers have poorer survival than non-Indigenous women: Explained by stage, comorbidity and treatment uptake', Asia Pac J Clin Oncol, 8 321 (2012)
2012Martin JH, Barras M, Yui NA, Kirkpatrick C, Kubler P, Norris R, 'Gentamicin Monitoring Practices in Teaching Hospitals ¿ Time to Undertake the Necessary Randomised Controlled Trial', J Clinic Toxicol, 2 146 (2012)
2012Martin JH, Coory M, Baade P, 'Challenges of an ageing and dispersed population for delivering cancer services in Australia: More than just doctors needed', Internal Medicine Journal, 42 349-351 (2012)
2012Martin JH, Coory MD, 'New medicines - urgent need to assess outcomes in special groups', Medical Journal of Australia, 196 433-434 (2012)
2011Martin JH, Garvey G, Cunningham J, Valery PC, Condon J, Roder D, et al., 'Reducing the burden of cancer for Aboriginal and Torres Strait Islander Australians: time for a coordinated, collaborative, priority-driven, Indigenous-led research program', Medical Journal of Australia, 194 530-531 (2011)
2011Martin JH, Jellis CL, Stanton T, Leano R, Marwick TH, 'Usefulness of at rest and exercise hemodynamics to detect subclinical myocardial disease in type 2 diabetes mellitus', American Journal of Cardiology, 107 615-621 (2011)
2011Martin JH, Jacka C, Garvey G, Sabesan S, Ghandi M, Baxi S, et al., 'Closing the Divide in Indigenous cancer: Cancer brochures for Indigenous patients and their families', Asia Pacific Journal of Clinical Oncology, 7 147 (2011)
2011Martin JH, Scott I, Mitchell C, Gray L, 'Optimising drug use in elderly populations ¿ pilot study of a drug minimization guide', Internal Medicine Journal, 41 14 (2011)
2011Martin JH, Jellis C, Sacre JW, Haluska B, Jenkins C, Marwick TH, 'Myocardial Dysfunction and Metabolic Derangement in Type 2 Diabetes: Relationship with Procollagen Biomarkers of Myocardial Fibrosis', Journal American College of Cardiology, 57 860 (2011)
2011Chachay VS, Kirkpatrick CMJ, Hickman IJ, Ferguson M, Prins JB, Martin JH, 'Resveratrol - pills to replace a healthy diet?', BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 72 27-38 (2011)
2011Martin JH, Fay MF, Udy A, Roberts J, Kirkpatrick C, Ungerer J, Lipman J, 'Pitfalls of using estimations of glomerular filtration rate in an intensive care population', INTERNAL MEDICINE JOURNAL, 41 537-543 (2011)
2011Martin JH, Deacon CF, Gorrell MD, Prins JB, 'Incretin-based therapies - review of the physiology, pharmacology and emerging clinical experience', Internal Medicine Journal, 41 299-307 (2011)
2011Martin JH, Kubler P, 'Treatment for pulmonary hypertension in Australia: too far too fast?', INTERNAL MEDICINE JOURNAL, 41 217-219 (2011)
2011McGloughlin S, Roberts JA, O'Donoghue S, Martin J, Briscoe S, Lipman J, 'Ganciclovir pharmacokinetics and suggested dosing in continuous venovenous haemodiafiltration', INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 37 90-92 (2011)
2011Martin JH, Jellis C, Wrigh J, Kennedy D, Sacre J, Jenkins C, et al., 'Association of Imaging Markers of Myocardial Fibrosis with Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy', Circulation: Cardiovascular Imaging, 4 693-702 (2011)
2011Mcneill GBS, Martin JH, 'How reliable is eGFR when calculating drug dosage in acute medical admissions?', Internal Medicine Journal, 41 327-331 (2011)
2010Martin JH, Connelly KA, Boyle A, Kompa A, Zhang Y, Kelly D, et al., 'Effect of Atorvastatin on Cardiac Remodelling and Mortality in Rats Following Hyperglycemia and Myocardial Infarction', INTERNATIONAL JOURNAL OF CARDIOLOGY, 143 353-360 (2010) [C1]
2010Scott KA, Martin JH, Inder WJ, 'Acidosis in the hospital setting: is metformin a common precipitant?', INTERNAL MEDICINE JOURNAL, 40 342-346 (2010)
2010Martin JH, Jellis CL, Narula J, Markwick TH, 'Assessment of nonischemic myocardial fibrosis', J. Am. Coll. Cardiol, 56 89-97 (2010)
2010Martin JH, Avent M, Pattullo C, Dines A, Kubler P, 'Drug Use Evaluation Services in Australia and New Zealand: A Neglected Area of Research?', J Pharm Pract Res, 40 15-18 (2010)
2010Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, Jones GR, 'Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.', The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists, 31 21-24 (2010)
2010Jellis CL, Jenkins C, Leano R, Martin JH, Marwick TH, 'Reduced end-systolic pressure-volume ratio response to exercise: A marker of subclinical myocardial disease in type 2 diabetes', Circulation: Cardiovascular Imaging, 3 443-449 (2010)
2010Protani M, Coory M, Martin JH, 'Effect of obesity on survival of women with breast cancer: Systematic review and meta-Analysis', Breast Cancer Research and Treatment, 123 627-635 (2010)
2010Hollingworth S, Duncan EL, Martin JH, 'Marked increase in proton pump inhibitors use in Australia', Pharmacoepidemiology and Drug Safety, 19 1019-1024 (2010)
2010Norris RL, Martin JH, Thompson E, Ray JE, Fullinfaw RO, Joyce D, et al., 'Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development', THERAPEUTIC DRUG MONITORING, 32 615-623 (2010)
2010Phillips LK, Peake JM, Zhang X, Hickman IJ, Kolade O, Sacre JW, et al., 'The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes', Journal of Clinical Endocrinology and Metabolism, 95 4455-4459 (2010)
2010Martin JH, Fay MF, 'Surrogate end-points in clinical practice: are we providing worse care?', INTERNAL MEDICINE JOURNAL, 40 395-398 (2010)
2010Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, Jones GRD, 'Guidelines Review - Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists', Clinical Biochemist Reviews, 31 21-24 (2010)
2010Martin JH, Jellis CL, Stanton T, Leano R, Markwick TH, 'Subclinical myocardial disease in type 2 diabetes: Mechanistic insights from resting and exercise haemodynamics', Heart Lung and Circulation, 19 S196 (2010)
2010Doogue MP, Martin JH, 'Editorial: Whither therapeutic drug monitoring?', Internal Medicine Journal, 40 671-672 (2010)
2010Siriwardane D, Woodman R, Hakendorf P, Martin JH, White GH, Ben-Tovim DI, Thompson CH, 'Stability of plasma creatinine concentrations in acute complex long-stay admissions to a general medical service', Clinical Medicine, Journal of the Royal College of Physicians of London, 10 540-543 (2010)
2009Doogue M, Martin J, Miners J, Somogyi A, 'Prescribing in liver disease', AUSTRALIAN PRESCRIBER, 32 120-120 (2009)
2009Martin JH, Morris R, Beer C, Doogue M, 'Doctors and the pharmaceutical industry: time for a national policy?', Medical Journal of Australia, 191 189-190 (2009)
2009Martin JH, 'Advances in anticoagulants', Australian Doctor, . (2009)
2009Martin JH, Ghiculescu A, 'Rapidly Progressive Severe Amiodarone-induced Hypothyroidism in an Elderly Female', Journal of Pharmacy Practice and Research, 39 140-141 (2009)
2009Martin JH, Doogue M, 'Editorial ¿ Guidelines or external regulation?', Internal Medicine Journal, 39 789-791 (2009)
2009Martin JH, Doogue M, Somogyi A, Miners J, 'Prescribing in liver disease. Letter in response to Australian Prescriber', Australian Prescriber, 32 32(2):32-35 & 32(5):120 (2009)
2009Sweidan M, Reeve JF, Brien J-AE, Jayasuriya P, Martin JH, Vernon GM, 'Quality of drug interaction alerts in prescribing and dispensing software REPLY', MEDICAL JOURNAL OF AUSTRALIA, 191 358-359 (2009)
2009Martin JH, Fay MF, Ungerer JP, 'eGFR - use beyond the evidence', MEDICAL JOURNAL OF AUSTRALIA, 190 197-199 (2009)
2009Sweidan M, Reeve JF, Brien J-AE, Jayasuriya P, Martin JH, Vernon GM, 'Quality of drug interaction alerts in prescribing and dispensing software', MEDICAL JOURNAL OF AUSTRALIA, 190 251-254 (2009)
2009Martin JH, Coory MD, Valery PC, Green AC, 'Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer', CANCER CAUSES & CONTROL, 20 355-360 (2009)
2009Martin JH, 'Pharmacogenetics of warfarin - is testing clinically indicated?', AUSTRALIAN PRESCRIBER, 32 76-80 (2009)
2009Howell S, Coory M, Martin J, Duckett S, 'Using routine inpatient data to identify patients at risk of hospital readmission', BMC HEALTH SERVICES RESEARCH, 9 (2009)
2009Martin JH, Beer C, Morris RG, Doogue MP, 'Doctors and the pharmaceutical industry: time for a national policy?', MEDICAL JOURNAL OF AUSTRALIA, 191 189-190 (2009)
2009Martin JH, Woods M, Mudge A, 'Old bugs new populations: an unusual presentation of pericarditis', INTERNAL MEDICINE JOURNAL, 39 850-851 (2009)
2009Martin JH, Mangiafico S, Kelly DJ, 'Role of statins in diabetes complications', Current Diabetes Reviews, 5 165-170 (2009)
2008Martin JH, Norris RL, Morris RG, Ray JE, Fullinfaw RO, Ilett KF, et al., 'A survey of Therapeutic Drug Monitoring in Australia and New Zealand', Clinical Biochemist Reviews, 29 Supp (iii) (2008)
2008Martin J, 'Statins and Congestive Heart Failure', CURRENT ATHEROSCLEROSIS REPORTS, 10 369-376 (2008)
2007Connelly KA, Kelly DJ, Martin JH, Zhang Y, Thai K, Krum H, Gilbert RE, 'Hyperglycaemia and an enhanced tissue RAS are necessary components in the pathogenesis of diabetic cardiac microvascular complications, mediated via PKC beta isoform', EUROPEAN HEART JOURNAL, 28 550-550 (2007)
2007Martin JH, Krum H, 'Statins and clinical outcomes in heart failure', CLINICAL SCIENCE, 113 119-127 (2007)
2007Kelly DJ, Zhang Y, Connelly K, Cox AJ, Martin J, Krum H, Gilbert RE, 'Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy', AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 293 H2860-H2869 (2007)
2007Martin JH, Connelly K, Kelly D, Zhang Y, Prior D, Cox A, et al., 'Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen202) 27 rat', Cardiovascular Research, 76 280-291 (2007)
2005Martin JH, See F, Kompa A, Lewis DA, Krum H, 'Fibrosis as a Therapeutic Target Post-Myocardial Infarction. Current Pharmaceutical Design', Current Pharmaceutical Design, 11 477-487 (2005)
2005Martin JH, Denver R, Bailey M, Krum H, 'In Vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling', Clinical and Experimental Pharmacology and Physiology, 32 697-701 (2005)
2005Martin JH, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, et al., 'Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-B¿', Cardiovascular Research, 65 694-701 (2005)
2003Martin J, Krum H, 'Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class - Are they clinically relevant?', DRUG SAFETY, 26 13-21 (2003)
2003Martin JH, Liew D, Krum H, 'Eplerenone (Pharmacia)', Curr Opin Investig Drugs, 4 316-322 (2003)
2003Martin JH, Mourton SM, Nicholls MG, 'Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient', New Zealand Medical Journal, 116 (2003)
2002Berakis A, Williams TJ, Naughton MT, Martin JH, Muhlmann M, Krum H, 'Altered sympathetic and parasympathetic activity in lung transplantation patients at rest and following autonomic perturbation', CHEST, 122 1192-1199 (2002)
2001Martin JH, 'Cytochrome P450 drug interactions: are they clinically relevent?', Australian Prescriber, 24 10-12 (2001)
2001Martin JH, Begg EJ, Kennedy MA, Roberts R, Barclay ML, 'Is cytochrome P4502C9 genotype associated with NSAID gastric ulceration?', BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 51 627-630 (2001)
2001Martin JH, 'The Heart Failure Journal Club: a review of publications on heart failure in American Heart Journal', Eur J Heart Failure, 3 125-137 (2001)
2001Martin JH, 'Cytochrome P450 drug interactions', Australian Prescriber, 24 80-81 (2001)
2001Martin JH, 'Eplerenone (GD Searle)', Current Opinion Invest Drugs, 2 521-524 (2001)
2001Martin JH, Fay MF, 'Capecitabine', Current Therapeutics, 42 49-51 (2001)
2001Martin JH, 'Diltiazem-mediated inhibition of sildenafil metabolism may promote nitrate-induced hypotension', Internal Medicine Journal, 31 374-374 (2001)
2001Martin JH, 'Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease', Pharmacological Research, 46 203-212 (2001)
2000Martin JH, Begg EJ, 'Reference pricing - is it in the public interest?', New Zealand Medical Journal, 113 422-425 (2000)
2000Martin JH, 'Drug prices not the whole story', Medical Observer, Melbourne, 24-24 (2000)
1999Martin JH, Begg EJ, 'OC'S - emotional journalism?', GP Weekly, . (1999)
1995Martin JH, Abbott G, 'Serum sickness-like illness and antimicrobials in children', New Zealand Medical Journal, 108 123-124 (1995)
Show 115 more

Review (1 outputs)

YearCitationAltmetricsLink
2013, 'Reviewer', Essentials of Internal Medicine, 3rd Edition (2013)

Conference (8 outputs)

YearCitationAltmetricsLink
2014Cheng M, Linda N, Protani M, Carroll J, Fay M, Martin J, 'OBESITY A RISK FACTOR FOR CHEMOTHERAPY DOSE REDUCTION IN BREAST CANCER: A MULTI-CENTERED APPROACH', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
2014Tam L, Meiklejohn J, Garvey G, Martin J, Adams J, Walpole E, et al., 'SUPPORTING ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE DIAGNOSED WITH CANCER TO NAVIGATE THE HEALTHCARE SYSTEM', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
2014Linda N, Cheng M, Protani M, Martin J, Fay M, 'RELATIONSHIP BETWEEN OBESE WOMEN WITH BREAST CANCER, THEIR SOCIOECONOMIC STATUS AND COMORBIDITIES', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
2010Putt MT, Roberts JA, Udy AA, Martin JH, Jarrett P, Salmon N, Lipman J, 'ASSESSMENT OF ADEQUACY OF LOADING DOSE OF PHENYTOIN (PTN) IN ADULT INTENSIVE CARE PATIENTS USING POPULATION PHARMACOKINETICS', INTENSIVE CARE MEDICINE, Barcelona, SPAIN (2010)
2009Norris R, Morris R, Thompson E, Ray J, Barras M, Jones G, Martin J, 'A Survey of Therapeutic Drug Monitoring in Australasia', THERAPEUTIC DRUG MONITORING, Montreal, CANADA (2009)
2006Martin JH, Connelly K, Boyle A, Kelly DJ, Kompa A, Zhang M, et al., 'Hyperglycemia has a detrimental effect on cardiac remodelling and mortality after myocardial infarction: benefit of statin therapy', EUROPEAN HEART JOURNAL, Barcelona, SPAIN (2006)
2004Martin JH, Kelly D, Misfud S, Zhang M, Krum H, Wilkinson-Berka J, Gilbert R, 'Tranilast dose-dependently attenuates extra-cellular matrix deposition in rats.', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, Glasgow, SCOTLAND (2004)
2003Martin JH, Denver R, Pepe S, Krum H, 'Direct, dose-dependent anti-fibrotic effects of atorvastatin in rat and human cardiac fibroblast cell culture', EUROPEAN HEART JOURNAL, VIENNA, AUSTRIA (2003)
Show 5 more
Edit

Grants and Funding

No funding.

Edit

Research Supervision

Number of current supervisions10
Total current UoN PhD EFTSL0.8

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20152015PhD (Clinical Pharm)Principal SupervisorPharmacokinetics and Pharmacodynamics of Synthetic Cannabinoids in Humans
20152019PhD (Clinical Pharm)Co-SupervisorDevelopmental and Environmental Determinants on Neonatal Pharmacology
2014 Masters Pharmacology
University of Queensland
Co-SupervisorCombined pharmacogenetics and kinetics in hematology
2014 Pharmacology
University of Queensland
Co-SupervisorPharmacovigilance of immunology medications
2013 PHD Pharmacology
University of Queensland
Co-Supervisor.
2012 Masters Pharmacology
University of Queensland
Co-Supervisor?
2012 PHD Pharmacology
University of Queensland
Consultant SupervisorHelping students structure knowledge for clinical use in PBL
2012 PHD Pharmacology
University of Queensland
Principal SupervisorEffect of obesity on mortality in breast cancer
2010 PHD Pharmacology
University of Queensland
Co-SupervisorThe role of resveratrol, a polyphenolic compound found in red grape skin, in the management of non-alcoholic fatty liver disease
2010 PHD Pharmacology
University of Queensland
Co-SupervisorCombined effect of diabetes and obesity on survival in cancer
Edit

Professor Jennifer Martin

Work Phone(02) 4921 1286
Fax(02) 4960 2088
Email
PositionChair of Clinical Pharmacology
School of Medicine and Public Health
School of Medicine and Public Health
Faculty of Health and Medicine
The University of Newcastle, Australia
Office
Calvary Mater Hospital, Newmed 2, Room 5.35,
Newmed 2,
Calvary Mater Hospital
URL:www.newcastle.edu.au/profile/jen-martin